Fusion of SARS-CoV-2 neutralizing LCB1 peptide with Bacillus amyloliquefaciens RNase improves antiviral efficacy.
Kostin NN, Bobik TV, Konovalova EV, Kocharovskaya MV, Simonova MA, Rushkevich NY, Mokrushina YA, Skryabin GA, Kalinin RS, Kovalchuk SI, Ziganshin RH, Kaluzhskiy LA, Gnedenko OV, Yablokov EO, Ivanov AS, Chernov AS, Kazakov VA, Khokhlova ON, Murashev AN, Hong S, Shramova EI, Schulga AA, Lyukmanova EN, Kirpichnikov MP, Smirnov IV, Belogurov AA, Rubtsov YP, Stepanov AV, Zhang H, Gabibov AG, Deyev SM.
Kostin NN, et al. Among authors: simonova ma.
Sci Rep. 2025 Jul 31;15(1):28039. doi: 10.1038/s41598-025-12444-2.
Sci Rep. 2025.
PMID: 40744985
Free PMC article.